{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:19:11Z","timestamp":1761743951607},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.2515\/therapie\/2014020","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T10:00:10Z","timestamp":1402653610000},"page":"175-177","source":"Crossref","is-referenced-by-count":5,"title":["Sirolimus-related Systemic Thrombotic Microangiopathy after Renal Transplantation"],"prefix":"10.1016","volume":"69","author":[{"given":"Simone","family":"Negrini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Durrbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Becquemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.2515\/therapie\/2014020_bb1835","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00003495-200767030-00004","article-title":"Use of sirolimus in solid organ transplantation","volume":"67","author":"Augustine","year":"2007","journal-title":"Drugs"},{"issue":"2","key":"10.2515\/therapie\/2014020_bb1840","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.healun.2010.08.010","article-title":"Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation","volume":"30","author":"Ahya","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.2515\/therapie\/2014020_bb1845","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1399-0012.2012.01677.x","article-title":"Sirolimus use and incidence of venous thromboembolism in cardiac transplant recipients","volume":"26","author":"Thibodeau","year":"2012","journal-title":"Clin Transplant"},{"issue":"1","key":"10.2515\/therapie\/2014020_bb1850","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ndt\/gfh334","article-title":"De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases","volume":"20","author":"Crew","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.2515\/therapie\/2014020_bb1855","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.2515\/therapie\/2014020_bb1860","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hoc.2012.02.014","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer therapy","volume":"26","author":"Gomez-Pinillos","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"10.2515\/therapie\/2014020_bb1865","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","article-title":"Thrombotic microangiopathy and associated renal disorders","volume":"27","author":"Barbour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.2515\/therapie\/2014020_bb1870","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.2515\/therapie\/2014020_bb1875","first-page":"235","article-title":"Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA","volume":"17","author":"Ardalan","year":"2006","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"10.2515\/therapie\/2014020_bb1880","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/gfq617","article-title":"The podocyte as a direct target of immunosuppressive agents","volume":"26","author":"Sch\u00f6nenberger","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.2515\/therapie\/2014020_bb1885","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.transproceed.2007.01.038","article-title":"Proteinuria in transplant patients associated with sirolimus","volume":"39","author":"Franco","year":"2007","journal-title":"Transplant Proc"},{"issue":"2","key":"10.2515\/therapie\/2014020_bb1890","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2215\/CJN.00340107","article-title":"Sirolimus: defining nephrotoxicity in the renal transplant recipient","volume":"2","author":"Tomlanovich","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.2515\/therapie\/2014020_bb1895","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archderm.135.5.553","article-title":"Systemic toxicity following administration of sirolimus (formerly rapamycin) for psoriasis: association of capillary leak syndrome with apoptosis of lesional lymphocytes","volume":"135","author":"Kaplan","year":"1999","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.2515\/therapie\/2014020_bb1900","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","article-title":"Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys","volume":"5","author":"Sartelet","year":"2005","journal-title":"Am J Transplant"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716309799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716309799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:49:01Z","timestamp":1554277741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716309799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0040595716309799"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2014020","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}